_id
6915e8c4bc934aba376b1b99
Ticker
PTHS
Name
Pelthos Therapeutics Inc.
Exchange
NYSE MKT
Address
4020 Stirrup Creek Drive, Durham, NC, United States, 27703
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pelthos.com
Description
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Last Close
27.41
Volume
11542
Current Price
25.215
Change
-2.66
Last Updated
2026-01-06T09:42:02.261Z
Image
data:image/webp;base64,UklGRjQBAABXRUJQVlA4ICgBAAAwCQCdASpAAEAAPrVSoUsnJSMhrBqqaOAWiWIA0evyHNcExaDbRgdwkd1036+edrP2eWuh+rlvDtxlubrWkWtLvvCcrAiB3qAlu89sVHdFWHK4AP75WEAO8Mf8zVVSB5yrlOawn2kNk0ivFfDJxUHuvGVIWMLpnbWVZUL8sWf/PDEtCuJQ/GJgtktOxX/tQU0JCZgbtxl/yttpWCCzjIk0BfuITRarcDBze9AyZy+DCO3oZuS/B6725zt1g0g86xe9QbPoVP1CzEtKLlahJoOWNGb7AVaexs6qmxn02+KwH6huLhnSMFmwdsfgafs6S/i6g6Qb9qmLERG3CRZW8LTFqmNXjMGS7GttveYl/pipftlNnDTCE8RxNG4SzGbX5/tUceABiAAAAA==
Ipo Date
2024-02-16T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.809
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
7406000
Cost Of Revenue
3384000
Gross Profit
4022000
Operating Expenses
19384000
Operating Income
-15362000
Interest Expense
1346000
Pretax Income
-16703000
Net Income
-16238000
Eps
-25.351356246038364
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-465000
EBITDA
-14215000
Operating Margin
-207.42641101809346
Total Other Income Expense Net
-1341000
Cash
14253000
Short Term Investments
-
Receivables
7988000
Inventories
24096000
Total Current Assets
49050000
Property Plant Equipment
13526000
Total Assets
126433000
Payables
5666000
Short Term Debt
631000
Long Term Debt
-
Total Liabilities
68180000
Equity
58253000
Bs_currency_symbol
USD
Depreciation
1142000
Change In Working Capital
-5033071
Cash From Operations
-15258729
Capital Expenditures
0
Cash From Investing
2761000
Cash From Financing
26692000
Net Change In Cash
14121683
Cf_currency_symbol
USD
PE
-
PB
0.2772502938904434
ROE
-27.874959229567576
ROA
-12.843165945599647
FCF
-15258729
Fcf Percent
-2.0603198757763974
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
3
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
2
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
7406000
Quarters > 0 > income Statement > cost Of Revenue
3384000
Quarters > 0 > income Statement > gross Profit
4022000
Quarters > 0 > income Statement > operating Expenses
19384000
Quarters > 0 > income Statement > operating Income
-15362000
Quarters > 0 > income Statement > interest Expense
1346000
Quarters > 0 > income Statement > pretax Income
-16703000
Quarters > 0 > income Statement > net Income
-16238000
Quarters > 0 > income Statement > eps
-25.351356246038364
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
640518
Quarters > 0 > income Statement > income Tax Expense
-465000
Quarters > 0 > income Statement > EBITDA
-14215000
Quarters > 0 > income Statement > operating Margin
-207.42641101809346
Quarters > 0 > income Statement > total Other Income Expense Net
-1341000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
14253000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7988000
Quarters > 0 > balance Sheet > inventories
24096000
Quarters > 0 > balance Sheet > total Current Assets
49050000
Quarters > 0 > balance Sheet > property Plant Equipment
13526000
Quarters > 0 > balance Sheet > total Assets
126433000
Quarters > 0 > balance Sheet > payables
5666000
Quarters > 0 > balance Sheet > short Term Debt
631000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
68180000
Quarters > 0 > balance Sheet > equity
58253000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-16238000
Quarters > 0 > cash Flow > depreciation
1142000
Quarters > 0 > cash Flow > change In Working Capital
-5033071
Quarters > 0 > cash Flow > cash From Operations
-15258729
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
2761000
Quarters > 0 > cash Flow > cash From Financing
26692000
Quarters > 0 > cash Flow > net Change In Cash
14121683
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-25.351356246038364
Quarters > 0 > ratios > PB
0.2772502938904434
Quarters > 0 > ratios > ROE
-27.874959229567576
Quarters > 0 > ratios > ROA
-12.843165945599647
Quarters > 0 > ratios > FCF
-15258729
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.0603198757763974
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3230423
Quarters > 1 > income Statement > operating Income
-3230423
Quarters > 1 > income Statement > interest Expense
218516
Quarters > 1 > income Statement > pretax Income
-3448939
Quarters > 1 > income Statement > net Income
-3448939
Quarters > 1 > income Statement > eps
-5.384609019574782
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
640518
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3230423
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-218516
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
59172
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
40400
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
822850
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
822850
Quarters > 1 > balance Sheet > payables
4988822
Quarters > 1 > balance Sheet > short Term Debt
2304687
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7317145
Quarters > 1 > balance Sheet > equity
-6494295
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3448939
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
2423630
Quarters > 1 > cash Flow > cash From Operations
-447145
Quarters > 1 > cash Flow > capital Expenditures
5
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
375000
Quarters > 1 > cash Flow > net Change In Cash
-72145
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-5.384609019574782
Quarters > 1 > ratios > PB
-2.486899866729183
Quarters > 1 > ratios > ROE
53.10721179127219
Quarters > 1 > ratios > ROA
-419.1455307771769
Quarters > 1 > ratios > FCF
-447150
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1833977
Quarters > 2 > income Statement > operating Income
-1833977
Quarters > 2 > income Statement > interest Expense
133634
Quarters > 2 > income Statement > pretax Income
-1967611
Quarters > 2 > income Statement > net Income
-1967611
Quarters > 2 > income Statement > eps
-3.210895377224246
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
612792
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1833977
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-133634
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
131317
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
40400
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
911179
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
911179
Quarters > 2 > balance Sheet > payables
2603605
Quarters > 2 > balance Sheet > short Term Debt
2503408
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5107013
Quarters > 2 > balance Sheet > equity
-4195834
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1967611
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
755441
Quarters > 2 > cash Flow > cash From Operations
-632126
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
250000
Quarters > 2 > cash Flow > net Change In Cash
-382126
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-3.210895377224246
Quarters > 2 > ratios > PB
-3.6825933247120832
Quarters > 2 > ratios > ROE
46.894395726809016
Quarters > 2 > ratios > ROA
-215.94121462412983
Quarters > 2 > ratios > FCF
-632126
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1825048
Quarters > 3 > income Statement > operating Income
-1825048
Quarters > 3 > income Statement > interest Expense
107966
Quarters > 3 > income Statement > pretax Income
-1926734
Quarters > 3 > income Statement > net Income
-1926734
Quarters > 3 > income Statement > eps
-3.2327155035729205
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
596011
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1818768
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-101686
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
513443
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
40400
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1369143
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1369143
Quarters > 3 > balance Sheet > payables
1897127
Quarters > 3 > balance Sheet > short Term Debt
2186070
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4083197
Quarters > 3 > balance Sheet > equity
-2714054
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1926734
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
649961
Quarters > 3 > cash Flow > cash From Operations
-670264
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-71196
Quarters > 3 > cash Flow > net Change In Cash
-741460
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-3.2327155035729205
Quarters > 3 > ratios > PB
-5.537258051976859
Quarters > 3 > ratios > ROE
70.99099723144786
Quarters > 3 > ratios > ROA
-140.72554875568147
Quarters > 3 > ratios > FCF
-670264
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
7571449
Annuals > 0 > income Statement > operating Income
-7571449
Annuals > 0 > income Statement > interest Expense
786393
Annuals > 0 > income Statement > pretax Income
-7955338
Annuals > 0 > income Statement > net Income
-7955338
Annuals > 0 > income Statement > eps
-13.538235594431775
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
587620
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7168945
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-383889
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
513443
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
40400
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1369143
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
1369143
Annuals > 0 > balance Sheet > payables
1897127
Annuals > 0 > balance Sheet > short Term Debt
2186070
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4083197
Annuals > 0 > balance Sheet > equity
-2714054
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7955338
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
34631
Annuals > 0 > cash Flow > cash From Operations
-5792483
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
6209535
Annuals > 0 > cash Flow > net Change In Cash
417052
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-13.538235594431775
Annuals > 0 > ratios > PB
-5.800304562842154
Annuals > 0 > ratios > ROE
293.1164228862064
Annuals > 0 > ratios > ROA
-581.0450771029762
Annuals > 0 > ratios > FCF
-5792483
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
6862284
Annuals > 1 > income Statement > operating Income
-6862284
Annuals > 1 > income Statement > interest Expense
518509
Annuals > 1 > income Statement > pretax Income
-7380793
Annuals > 1 > income Statement > net Income
-7380793
Annuals > 1 > income Statement > eps
-12.797169320609205
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
576752
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-6862284
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-518509
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
96391
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
96391
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
96391
Annuals > 1 > balance Sheet > payables
4620925
Annuals > 1 > balance Sheet > short Term Debt
1268685
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6540943
Annuals > 1 > balance Sheet > equity
-6444552
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7380793
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
2051077
Annuals > 1 > cash Flow > cash From Operations
-981031
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1022348
Annuals > 1 > cash Flow > net Change In Cash
41317
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-12.797169320609205
Annuals > 1 > ratios > PB
-2.397557825586635
Annuals > 1 > ratios > ROE
114.52763512498618
Annuals > 1 > ratios > ROA
-7657.139151995519
Annuals > 1 > ratios > FCF
-981031
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2318159
Annuals > 2 > income Statement > operating Income
-2318159
Annuals > 2 > income Statement > interest Expense
140430
Annuals > 2 > income Statement > pretax Income
-2458589
Annuals > 2 > income Statement > net Income
-2458589
Annuals > 2 > income Statement > eps
-4.262818334396759
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
576752
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-2318159
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-140430
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
55074
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
55074
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
55074
Annuals > 2 > balance Sheet > payables
2993920
Annuals > 2 > balance Sheet > short Term Debt
540430
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3761611
Annuals > 2 > balance Sheet > equity
-3706537
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2458589
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
640864
Annuals > 2 > cash Flow > cash From Operations
-1567149
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1622223
Annuals > 2 > cash Flow > net Change In Cash
55074
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.262818334396759
Annuals > 2 > ratios > PB
-4.1686312803568395
Annuals > 2 > ratios > ROE
66.33116032566248
Annuals > 2 > ratios > ROA
-4464.155499872899
Annuals > 2 > ratios > FCF
-1567149
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
838996
Annuals > 3 > income Statement > operating Income
-838996
Annuals > 3 > income Statement > interest Expense
253
Annuals > 3 > income Statement > pretax Income
-595387
Annuals > 3 > income Statement > net Income
-595387
Annuals > 3 > income Statement > eps
-1.0323102477321275
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
576752
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-595134
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
243609
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
0
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
0
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
0
Annuals > 3 > balance Sheet > payables
2580317
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3680267
Annuals > 3 > balance Sheet > equity
-3680267
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-595387
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-755831
Annuals > 3 > cash Flow > cash From Operations
-1593011
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
1593011
Annuals > 3 > cash Flow > net Change In Cash
0
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0323102477321275
Annuals > 3 > ratios > PB
-4.198387258315769
Annuals > 3 > ratios > ROE
16.177820793980437
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-1593011
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
27
Valuation > metrics > PE
-25.351356246038364
Valuation > metrics > PB
0.2772502938904434
Valuation > final Score
70
Valuation > verdict
72.3% Undervalued
Profitability > metrics > ROE
-27.874959229567576
Profitability > metrics > ROA
-33.10499490316004
Profitability > metrics > Net Margin
-2.1925465838509317
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1704118242837278
Risk > metrics > Interest Coverage
-11.413075780089153
Risk > final Score
-16
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.789423535016675
Liquidity > metrics > Quick Ratio
3.9628394473558837
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-29
Prev Risks > 1
-25
Prev Risks > 2
-38
Prev Liquidities > 0
16
Prev Liquidities > 1
19
Prev Liquidities > 2
27
Updated At
2026-01-20T22:26:17.548Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-3.38
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-5.3
Earnings History > 1 > eps Estimate
-0.57
Earnings History > 1 > eps Difference
-4.73
Earnings History > 1 > surprise Percent
-829.8246
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-5.38
Earnings History > 2 > eps Estimate
-6.26
Earnings History > 2 > eps Difference
0.88
Earnings History > 2 > surprise Percent
14.0575
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-3.2109
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-2.9
Earnings History > 4 > eps Estimate
-2.3
Earnings History > 4 > eps Difference
-0.6
Earnings History > 4 > surprise Percent
-26.087
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-3.1
Earnings History > 5 > eps Estimate
-2.9
Earnings History > 5 > eps Difference
-0.2
Earnings History > 5 > surprise Percent
-6.8966
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-29
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-5.4622
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANew $50M boost backs first at-home treatment for kids’ skin virus Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pelthos Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-3.38
Date
2025-09-30
EPS Actual
-5.3
EPS Estimate
-0.57
EPS Difference
-4.73
Surprise Percent
-829.8246%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.